Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer
2003
Call for NICE to Review Chemotherapy Guidance for Colorectal Cancer
Sample size: 1000
Editorial
Author Information
Author(s): Mark P Saunders, Juan W Valle
Primary Institution: Christie Hospital NHS Trust
Conclusion
The authors argue that NICE has misinterpreted positive studies and should review their guidance on chemotherapy for colorectal cancer.
Supporting Evidence
- NICE's guidance is based on the FOCUS study, which the authors argue misinterprets other positive studies.
- Patients are concerned about the influence of funding constraints on NICE's recommendations.
Takeaway
The authors believe that the guidelines for treating colorectal cancer are not fair and need to be updated to help more patients.
Potential Biases
Concerns that NICE's guidance may be influenced by government funding rather than clinical effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website